{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:17:16Z","timestamp":1777911436542,"version":"3.51.4"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013543","name":"European Society for Paediatric Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Anamnestic 13-valent pneumococcal conjugate vaccine immunization did not affect the relapse risk in pediatric idiopathic nephrotic syndrome. Pneumococcal serotype (PS)-specific antibody titers increased significantly in all groups. Children receiving immunomodulatory treatments (IMTs) displayed significantly lower levels of PS-specific antibodies for 3\/8 serotypes tested. PS-specific B-cell counts significantly increased only in healthy controls and patients receiving corticosteroids.<\/jats:p>","DOI":"10.1093\/jpids\/piae057","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:45:55Z","timestamp":1717447555000},"page":"363-367","source":"Crossref","is-referenced-by-count":2,"title":["Immunogenicity, Immunological Memory and Monitoring of Disease Activity Following an Anamnestic Immunization With the 13-Valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome"],"prefix":"10.1093","volume":"13","author":[{"given":"Konstantina","family":"Kitsou","sequence":"first","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, First Department of Pediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Askiti","sequence":"additional","affiliation":[{"name":"Department of Nephrology, \u201cP. and A. Kyriakou\u201d Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Tzanoudaki","sequence":"additional","affiliation":[{"name":"Department of Immunology and Histocompatibility, Specific Reference Centre for Primary Immunodeficiencies-Paediatric Immunology, \u201cAghia Sophia\u201d Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andromachi","family":"Mitsioni","sequence":"additional","affiliation":[{"name":"Department of Nephrology, \u201cP. and A. Kyriakou\u201d Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Papadatou","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, First Department of Pediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Liatsis","sequence":"additional","affiliation":[{"name":"Department of Immunology and Histocompatibility, Specific Reference Centre for Primary Immunodeficiencies-Paediatric Immunology, \u201cAghia Sophia\u201d Children\u2019s Hospital , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kanaka-Gantenbein","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Medical School, Aghia Sophia Children\u2019s Hospital, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-4753","authenticated-orcid":false,"given":"Gkikas","family":"Magiorkinis","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, First Department of Pediatrics, \u201cAghia Sophia\u201d Children\u2019s Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"2024072014062439200_CIT0001","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"2024072014062439200_CIT0002","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1016\/j.vaccine.2011.07.053","article-title":"Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome","volume":"29","author":"Liakou","year":"2011","journal-title":"Vaccine"},{"key":"2024072014062439200_CIT0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-010-0330-z","article-title":"Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome","volume":"14","author":"Kanai","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"2024072014062439200_CIT0004","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2024072014062439200_CIT0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cyto.a.24654","article-title":"Development of a novel flow cytometry method for detecting pneumococcal-specific B cells","volume":"101","author":"Tzovara","year":"2022","journal-title":"Cytometry A"},{"key":"2024072014062439200_CIT0006","doi-asserted-by":"crossref","first-page":"602826","DOI":"10.3389\/fimmu.2021.602826","article-title":"Evaluation of immune and vaccine competence in steroid-sensitive nephrotic syndrome pediatric patients","volume":"12","author":"Colucci","year":"2021","journal-title":"Front Immunol"},{"key":"2024072014062439200_CIT0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15751-6","article-title":"Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin","volume":"11","author":"Jacques","year":"2020","journal-title":"Nat Commun"},{"key":"2024072014062439200_CIT0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.04051.x","article-title":"Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help","volume":"159","author":"Heidt","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2024072014062439200_CIT0009","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/cei.12604","article-title":"Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells","volume":"180","author":"De Bruyne","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2024072014062439200_CIT0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines7010013","article-title":"The Role of serotype-specific immunological memory in pneumococcal vaccination: current knowledge and future prospects","volume":"7","author":"Papadatou","year":"2019","journal-title":"Vaccines"},{"key":"2024072014062439200_CIT0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40272-023-00584-9","article-title":"20-Valent pneumococcal conjugate vaccine: pediatric first approval","volume":"25","author":"Shirley","year":"2023","journal-title":"Paediatr Drugs"},{"key":"2024072014062439200_CIT0012","doi-asserted-by":"crossref","first-page":"e1006904","DOI":"10.1371\/journal.ppat.1006904","article-title":"Polyvalent vaccines: high-maintenance heroes","volume":"14","author":"Schlingmann","year":"2018","journal-title":"PLoS Pathog"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piae057\/58064150\/piae057.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/7\/363\/58603894\/piae057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/13\/7\/363\/58603894\/piae057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T14:30:50Z","timestamp":1721485850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/13\/7\/363\/7686994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,3]]},"published-print":{"date-parts":[[2024,7,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piae057","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,3]]}}}